Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $4.2 Million Initial Public Offering of Polyrizon Ltd. 

New York, NY – October 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as sole book running manager in the initial public offering of Polyrizon Ltd. (Nasdaq: PLRZ), a development stage biotech company specializing in the development of innovative medical device hydrogels.  The SRFC team was led by partners Gregory Sichenzia, Jeff Cahlon, Avital Perlman and associates Christian Lichtenberger and Mayank Pradhan.